|
|
|
Volumn 61, Issue 1, 2015, Pages 11-19
|
|
Chronic hepatitis C: treat everyone now or stratify by disease?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
NS-5 PROTEIN, HEPATITIS C VIRUS;
VIRUS PROTEIN;
ANTAGONISTS AND INHIBITORS;
CARCINOMA, HEPATOCELLULAR;
COMPLICATION;
DRUG COMBINATION;
DRUG EFFECTS;
ECONOMICS;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MIXED INFECTION;
PERSONALIZED MEDICINE;
PRACTICE GUIDELINE;
SEVERITY OF ILLNESS INDEX;
TIME;
TREATMENT OUTCOME;
VIROLOGY;
VIRUS LOAD;
WATCHFUL WAITING;
ANTIVIRAL AGENTS;
CARCINOMA, HEPATOCELLULAR;
COINFECTION;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HIV INFECTIONS;
HUMANS;
INDIVIDUALIZED MEDICINE;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
PRACTICE GUIDELINES AS TOPIC;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
VIRAL LOAD;
VIRAL NONSTRUCTURAL PROTEINS;
WATCHFUL WAITING;
|
|
EID: 84936748275
PISSN: 1121421X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
